• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ATRIUM MEDICAL CORPORATION VXT VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ATRIUM MEDICAL CORPORATION VXT VASCULAR GRAFT Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problem Fluid Discharge (2686)
Event Type  Injury  
Manufacturer Narrative
We are in the process of performing the investigation and will submit the follow-up report once the evaluation is completed.Related mdr reports: 1219977-2016-00107, 1219977-2016-00108, 1219977-2016-00109, 1219977-2016-00110, 1219977-2016-00111.
 
Event Description
Report received indicates that the implanted graft exhibited weeping the entire length of the graft several days after the procedure.
 
Manufacturer Narrative
The lot number was not provided so a device history record could not be performed and the graft was not returned therefore the root cause could not be identified.Several attempts were made to obtain additional information regarding the complaint and the complainant provided no additional details except that no further surgery was needed following the event and the graft still remains implanted in the patient.All graft lots undergo inspection and testing prior to release per internal quality procedures.The inspection and testing includes the following: longitudinal tensile strength, radial tensile strength, water entry pressure, suture retention, 100% visual and tactile inspection.All testing requirements are reviewed and verified prior to releasing the graft lots.Peri-graft seroma is defined as a sterile collection of fluid confined within a non-secretory fibrous pseudo-membrane surrounding a vascular graft.The instructions for use advise to properly size the tunneler instruments to prevent peri-graft seroma formation.It also warns against applying excessive tension to the anastomosis.The instructions for use list weeping/seroma as an adverse reaction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VXT VASCULAR GRAFT
Type of Device
VXT VASCULAR
Manufacturer (Section D)
ATRIUM MEDICAL CORPORATION
hudson NH 03051
Manufacturer (Section G)
ATRIUM MEDICAL CORPORATION
5 wentworth drive
hudson NH 03051
Manufacturer Contact
lori gosselin
40 continental blvd
merrimack, NH 03054
6038645366
MDR Report Key5752667
MDR Text Key48300942
Report Number1219977-2016-00138
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeFR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/14/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/14/2016
Initial Date FDA Received06/27/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received07/19/2016
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-